Hypothesis: Using the Warburg effect against cancer by reducing glucose and providing lactate

Medical Hypotheses

Volumn 73, Issue 1, 2009, Pages 48-51

  Nijsten, Maarten W N ^a   van Dam, Gooitzen M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; LACTIC ACID; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESEARCH; GLUCOSE UTILIZATION; GLYCOLYSIS; HUMAN; HYPOGLYCEMIA; LIMB PERFUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; TUMOR GROWTH;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; GLUCOSE; HUMANS; INSULIN; LACTIC ACID; MODELS, BIOLOGICAL; NEOPLASMS;

ANIMALIA;

EID: 64749090748     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.01.041     Document Type: Article

References (19)

1. Warburg O. On the origin of cancer cells. Science 123 (1956) 309-314
2. Gillies R.J., and Gatenby R.A. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?. J Bioenerg Biomembr 39 (2007) 251-257
3. Denko N.C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8 (2008) 705-713
4. Lopez-Rios F., Sanchez-Arago M., Garcia-Garcia E., et al. Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. Cancer Res 67 (2007) 9013-9017
5. Walenta S., and Mueller-Klieser W. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 14 (2004) 267-274
6. Ko Y.H., Pedersen P.L., and Geschwind J.F. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett 173 (2001) 83-91
7. McCarty M.F. Prospects for glycerol-rescued hypoglycaemia as a cancer therapy. Med Hypotheses 56 (2001) 286-289
8. Huckabee W.E. Abnormal resting blood lactate. The significance of hyperlactate-mia in hospitalized patients. Am J Med 30 (1961) 833-839
9. Brooks G.A. Lactate shuttles in nature. Biochem Soc Trans 30 (2002) 258-264
10. Cole L., Bellomo R., Baldwin I., Hayhoe M., and Ronco C. The impact of lactate-buffered high-volume hemofiltration on acid base balance. Intensive Care Med 29 (2003) 1113-1120
11. Borg M.A., Tamborlane W.V., Shulman G.I., and Sherwin R.S. Local lactate perfusion of the ventromedial hypothalamus suppresses hypoglycaemic counterregulation. Diabetes 52 (2003) 663-666
12. Maran A., Cranston I., Lomas J., MacDonald I., and Amiel S.A. Protection by lactate of cerebral function during hypoglycaemia. Lancet 343 (1994) 16-20
13. Vriesendorp T.M., van Santen S., DeVries J.H., et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 34 (2006) 96-101
14. de Wilt J.H., Manusama E.R., van Tiel S.T., van Ijken M.G., ten Hagen T.L., and Eggermont A.M. Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats. Br J Cancer 80 (1999) 161-166
15. Eggermont A.M. Isolated limb perfusion in the management of locally advanced extremity soft tissue sarcoma. Surg Oncol Clin N Am 12 (2003) 469-483
16. Edinger M., Cao Y.A., Hornig Y.S., et al. Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 38 (2002) 2128-2136
17. O'Neil R.G., Wu L., and Mullani N. Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells. Mol Imaging Biol 7 (2005) 388-392
18. Matsumoto S., Hyodo F., Subramanian S., et al. Low-field paramagnetic resonance imaging of tumor oxygenation and glycolytic activity in mice. J Clin Invest 118 (2008) 1965-1973
19. Sonveaux P., Végran F., Schroeder T., et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118 (2008) 3930-3942